ACRS News & Analysis

Aclaris Therapeutics (ACRS) Reports $1.36M Stock Sale by Insider

Leonard Braden Michael sold $1.36 million worth of stock in Aclaris Therapeutics (ACRS). This transaction adds to the ongoing scrutiny of insider trading activities at the company. The sale signifies potential shifts in the company's stock sensitivity to insider activities, which can influence investor sentiment. The impact of such insider sales on market perceptions often varies and depends on the overall performance and outlook of Aclaris Therapeutics.